{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-028683","form_type":"8-K","ticker":"NXGL","cik":"0001468929","company_name":"NEXGEL, INC.","filed_at":"2023-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.015347+00:00","generated_at":"2026-06-11T10:44:55.930826+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"NexGel Q2 revenue $1.17M (+108% YoY), net loss improved to $0.13/sh","bullets":["Revenue $1.17M (+108% YoY), exceeding projections; contract manufacturing +174% YoY.","Net loss improved to $687k ($0.13/sh) from $1M loss ($0.19/sh) in Q2 2022.","Gross profit $175k (15% margin) vs $101k (18%) in prior-year quarter.","Cash and equivalents $4.3M as of March 31, 2023; invested in inventory and capex for H2 demand.","New JV with C.G. Laboratories, strategic relationship with Enigma Health, and new supply agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-028683","json":"https://secwatch.observer/filing/0001493152-23-028683.json","markdown":"https://secwatch.observer/filing/0001493152-23-028683.md","text":"https://secwatch.observer/filing/0001493152-23-028683.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468929/000149315223028683/0001493152-23-028683-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468929/000149315223028683/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T10:44:55.930826+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1f578ea2771ef628425a5b7fe92e9493e69f3aea","claim":"NEXGEL, INC. reported the quarter ended June 30, 2023 results: revenue $1.17 million, net income $687 thousand or $0.13 per basic and diluted share, EPS $0.13 per basic and diluted share.","evidence_excerpt":"For the second quarter of 2023, revenue totaled $1.17 million, an increase of $606 thousand or 108%, as compared to $561 thousand for the same period the year prior.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315223028683/0001493152-23-028683-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"$1.17 million"},{"label":"Net income","value":"$687 thousand or $0.13 per basic and diluted share"},{"label":"EPS","value":"$0.13 per basic and diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}